Monday, January 9, 2023

Novel T cell receptor therapy shows early anti-tumor activity

Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A4 cancer antigen, achieved clinically significant results for patients with multiple solid tumor types in a Phase I clinical trial.

from Latest Science News -- ScienceDaily https://ift.tt/Vq8krah
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Claude Fable 5 AI finds a tiny formula that topples an 87-year-old math conjecture

A mathematician working at Anthropic says he used the AI model Claude Fable 5 to uncover a remarkably simple counterexample to the Jacobian ...